AI assistant
Reckitt Benckiser Group PLC — Board/Management Information 2018
Dec 13, 2018
4872_rns_2018-12-13_2b67d82f-2cb7-44b9-8e95-dc068506a0d5.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information
You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.
RNS Number : 3880K
Reckitt Benckiser Group PLC
13 December 2018
13 December 2018
RECKITT BENCKISER GROUP PLC
BOARD AND COMMITTEE CHANGES
Reckitt Benckiser Group plc ("RB") today announces the following changes to its Board and Committee membership.
Having served on the Board since October 2008 and having led the succession process for the new Chairman in 2017, André Lacroix, Senior Independent Director, Chair of the Audit Committee and member of the Nomination Committee, has decided to step down from the Board and will retire as a Director on 31 December 2018.
Effective 1 January 2019 Nicandro Durante is appointed as Senior Independent Director and Andrew Bonfield is appointed as Chair of the Audit Committee. Each of them will also join the Nomination Committee from that date.
Chris Sinclair, RB Chairman, said "Andre has been a great contributor to the Board over a period of many years, over which RB has seen tremendous growth and success. As SID, he led the succession process for a new Chairman last year. As a member and more recently Chairman of the Audit Committee he brought a rigorous and disciplined approach to risk management and assurance. On behalf of the Board, I would like to offer him enormous thanks."
For further Information:
Rupert Bondy
Company Secretary
+44 (0) 1753 217 800
Richard Joyce
SVP, Investor Relations
+44 (0)1753 217 800
Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
BOAGGGGCPUPRUBW